Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Insmed - 25 Year Stock Price History | INSM

Historical daily share price chart and data for Insmed since 2000 adjusted for splits and dividends. The latest closing stock price for Insmed as of January 23, 2025 is 77.84.
  • The all-time high Insmed stock closing price was 195.00 on August 30, 2000.
  • The Insmed 52-week high stock price is 80.53, which is 3.5% above the current share price.
  • The Insmed 52-week low stock price is 21.92, which is 71.8% below the current share price.
  • The average Insmed stock price for the last 52 weeks is 56.17.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Insmed Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 70.6593 69.9500 78.4500 65.2500 77.8400 12.75%
2024 53.5032 29.9400 79.0100 22.0000 69.0400 122.78%
2023 21.8217 19.1800 31.7400 16.2600 30.9900 55.11%
2022 21.8800 28.1300 28.2100 16.9800 19.9800 -26.65%
2021 30.5951 33.4200 44.3000 22.4600 27.2400 -18.17%
2020 28.2231 23.6600 40.5400 13.6300 33.2900 39.41%
2019 23.3077 13.9700 32.1900 13.9100 23.8800 82.01%
2018 22.6387 32.4600 32.9900 11.6000 13.1200 -57.92%
2017 20.2914 13.0800 31.7800 11.6100 31.1800 135.68%
2016 12.7351 17.2400 17.2400 9.0500 13.2300 -27.11%
2015 20.7534 15.9600 27.5400 14.1600 18.1500 17.32%
2014 15.7364 17.1400 21.5400 11.6500 15.4700 -9.00%
2013 11.2478 6.9600 17.3300 5.7200 17.0000 154.11%
2012 4.3827 3.1500 8.0000 2.7000 6.6900 119.34%
2011 6.4065 6.4000 13.1500 2.6400 3.0500 -51.65%
2010 8.1390 7.7000 12.5000 5.7000 6.3080 -18.08%
2009 9.7689 4.9000 24.7000 4.1500 7.7000 64.71%
2008 6.0865 8.3000 9.1000 3.4990 4.6750 -43.33%
2007 8.8034 9.0000 15.6000 5.7700 8.2500 -6.25%
2006 16.1210 21.3000 31.2000 8.5000 8.8000 -55.33%
2005 12.6992 23.0000 23.0000 8.2000 19.7000 -10.41%
2004 23.1546 30.3000 40.9000 10.1000 21.9900 -25.96%
2003 20.0198 4.8000 34.2000 4.1000 29.7000 561.47%
2002 17.7447 39.4000 39.4000 3.5000 4.4900 -88.25%
2001 45.0069 37.5000 89.9000 24.7000 38.2000 10.12%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $14.035B $0.305B
Insmed is a biopharmaceutical company engaged in the development and commercialization of ARIKAYCE, or liposomal amikacin for inhalation, for at least two identified orphan patient populations: patients with nontuberculous mycobacteria (NTM) lung infections and cystic fibrosis (CF) patients with Pseudomonas aeruginosa lung infections. Insmed is also focused on the development of INS1009, the company's inhaled treprostinil prodrug for the treatment of pulmonary arterial hypertension (PAH), a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $146.983B 14.23
Gilead Sciences (GILD) United States $115.953B 21.00
Bristol Myers Squibb (BMY) United States $115.789B 48.79
Vertex Pharmaceuticals (VRTX) United States $110.223B 0.00
CSL (CSLLY) Australia $81.857B 0.00
Regeneron Pharmaceuticals (REGN) United States $74.728B 17.01
GSK (GSK) United Kingdom $69.286B 8.02
Argenex SE (ARGX) Netherlands $38.626B 0.00
Alnylam Pharmaceuticals (ALNY) United States $34.379B 0.00
BioNTech SE (BNTX) Germany $27.611B 0.00
Illumina (ILMN) United States $22.261B 81.13
BeiGene (ONC) Cayman Islands $21.715B 0.00
Biogen (BIIB) United States $20.801B 8.93
Moderna (MRNA) United States $14.815B 0.00
Incyte (INCY) United States $13.950B 0.00
Genmab (GMAB) Denmark $13.877B 20.36
Genmab (GNMSF) Denmark $13.856B 16.62
Intra-Cellular Therapies (ITCI) United States $13.480B 0.00
Bio-Techne Corp (TECH) United States $12.506B 48.29
BioMarin Pharmaceutical (BMRN) United States $11.820B 27.44
Sarepta Therapeutics (SRPT) United States $11.089B 100.08
Vaxcyte (PCVX) United States $10.799B 0.00
QIAGEN (QGEN) Netherlands $10.783B 22.18
Exact Sciences (EXAS) United States $10.140B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $10.075B 41.62
Bio-Rad Laboratories (BIO.B) United States $9.769B 33.20
Exelixis (EXEL) United States $9.390B 21.35
Repligen (RGEN) United States $9.348B 121.78
Roivant Sciences (ROIV) United Kingdom $8.124B 0.00
Ascendis Pharma (ASND) Denmark $7.636B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.305B 7.15
Zealand Pharma (ZLDPF) Denmark $7.163B 0.00
Blueprint Medicines (BPMC) United States $7.056B 0.00
Halozyme Therapeutics (HALO) United States $7.033B 15.89
Revolution Medicines (RVMD) United States $6.884B 0.00
Legend Biotech (LEGN) United States $6.838B 0.00
Guardant Health (GH) United States $5.832B 0.00
Nuvalent (NUVL) United States $5.778B 0.00
Telix Pharmaceuticals (TLX) Australia $5.704B 0.00
Cytokinetics (CYTK) United States $5.525B 0.00
Axsome Therapeutics (AXSM) United States $4.956B 0.00
Alkermes (ALKS) Ireland $4.888B 16.42
TG Therapeutics (TGTX) United States $4.536B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $4.441B 0.00
Krystal Biotech (KRYS) United States $4.414B 73.08
Scholar Rock Holding (SRRK) United States $4.375B 0.00
Biohaven (BHVN) United States $4.102B 0.00
Alvotech (ALVO) Luxembourg $4.007B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.965B 0.00
ADMA Biologics Inc (ADMA) United States $3.893B 41.17
Viking Therapeutics (VKTX) United States $3.794B 0.00
Apellis Pharmaceuticals (APLS) United States $3.780B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.773B 0.00
Avidity Biosciences (RNA) United States $3.589B 0.00
Arcellx (ACLX) United States $3.561B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.517B 0.00
PTC Therapeutics (PTCT) United States $3.477B 0.00
Immunovant (IMVT) United States $3.410B 0.00
Denali Therapeutics (DNLI) United States $3.355B 0.00
Twist Bioscience (TWST) United States $3.107B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.011B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.988B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.963B 22.83
Zai Lab (ZLAB) China $2.914B 0.00
NovoCure (NVCR) Jersey $2.903B 0.00
Vericel (VCEL) United States $2.889B 975.50
Kymera Therapeutics (KYMR) United States $2.858B 0.00
Amicus Therapeutics (FOLD) United States $2.851B 0.00
Merus (MRUS) Netherlands $2.782B 0.00
SpringWorks Therapeutics (SWTX) United States $2.604B 0.00
Edgewise Therapeutics (EWTX) United States $2.570B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.472B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.453B 0.00
CG Oncology (CGON) United States $2.297B 0.00
ImmunityBio (IBRX) United States $2.244B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.243B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.205B 18.32
Protagonist Therapeutics (PTGX) United States $2.198B 13.86
Ligand Pharmaceuticals (LGND) United States $2.189B 54.65
Beam Therapeutics (BEAM) United States $2.185B 0.00
Vera Therapeutics (VERA) United States $2.138B 0.00
Bavarian Nordic (BVNRY) Denmark $2.138B 13.10
Janux Therapeutics (JANX) United States $2.109B 0.00
Certara (CERT) United States $2.091B 59.04
Mesoblast (MESO) Australia $2.016B 0.00
IDEAYA Biosciences (IDYA) United States $2.000B 0.00
Agios Pharmaceuticals (AGIO) United States $1.942B 0.00
NeoGenomics (NEO) United States $1.861B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.839B 0.00
Iovance Biotherapeutics (IOVA) United States $1.826B 0.00
Belite Bio (BLTE) United States $1.819B 0.00
Geron (GERN) United States $1.807B 0.00
WAVE Life Sciences (WVE) Singapore $1.778B 0.00
Apogee Therapeutics (APGE) United States $1.752B 0.00
Akero Therapeutics (AKRO) United States $1.746B 0.00
Disc Medicine (IRON) United States $1.741B 0.00
MannKind (MNKD) United States $1.702B 44.07
Fortrea Holdings (FTRE) United States $1.659B 52.86
Dynavax Technologies (DVAX) United States $1.633B 95.54
Celldex Therapeutics (CLDX) United States $1.608B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.605B 0.00
Structure Therapeutics (GPCR) United States $1.600B 0.00
Galapagos (GLPG) Belgium $1.577B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.552B 0.00
Travere Therapeutics (TVTX) United States $1.519B 0.00
Praxis Precision Medicines (PRAX) United States $1.483B 0.00
Viridian Therapeutics (VRDN) United States $1.454B 0.00
Vir Biotechnology (VIR) United States $1.450B 0.00
Novavax (NVAX) United States $1.414B 0.00
Nurix Therapeutics (NRIX) United States $1.394B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.387B 0.00
MiMedx (MDXG) United States $1.321B 34.58
Arvinas (ARVN) United States $1.252B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.248B 0.00
Arcus Biosciences (RCUS) United States $1.226B 0.00
ANI Pharmaceuticals (ANIP) United States $1.223B 16.67
Syndax Pharmaceuticals (SNDX) United States $1.195B 0.00
Adaptive Biotechnologies (ADPT) United States $1.182B 0.00
Liquidia Technologies (LQDA) United States $1.181B 0.00
Spyre Therapeutics (SYRE) United States $1.122B 0.00
Intellia Therapeutics (NTLA) United States $1.121B 0.00
Myriad Genetics (MYGN) United States $1.118B 0.00
AbCellera Biologics (ABCL) Canada $1.043B 0.00
Pacira BioSciences (PCRX) United States $1.037B 9.76
Pharvaris (PHVS) Netherlands $1.022B 0.00
Zymeworks (ZYME) United States $1.010B 0.00
Gyre Therapeutics (GYRE) United States $1.001B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.955B 0.00
Oculis Holding AG (OCS) Switzerland $0.919B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.911B 0.00
Cogent Biosciences (COGT) United States $0.906B 0.00
ArriVent BioPharma (AVBP) United States $0.897B 0.00
Nuvation Bio (NUVB) United States $0.892B 0.00
Replimune (REPL) United States $0.891B 0.00
CureVac (CVAC) Germany $0.887B 7.20
Septerna (SEPN) United States $0.861B 0.00
Anavex Life Sciences (AVXL) United States $0.847B 0.00
Tyra Biosciences (TYRA) United States $0.800B 0.00
Avid Bioservices (CDMO) United States $0.796B 0.00
Sana Biotechnology (SANA) United States $0.781B 0.00
Prothena (PRTA) Ireland $0.776B 0.00
GRAIL (GRAL) United States $0.761B 0.00
CorMedix Inc (CRMD) United States $0.746B 0.00
Castle Biosciences (CSTL) United States $0.746B 133.10
UniQure (QURE) Netherlands $0.745B 0.00
Cytek Biosciences (CTKB) United States $0.743B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.741B 0.00
89BIO (ETNB) United States $0.716B 0.00
Oric Pharmaceuticals (ORIC) United States $0.697B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.696B 0.00
LENZ Therapeutics (LENZ) United States $0.673B 0.00
Dianthus Therapeutics (DNTH) United States $0.671B 0.00
Pliant Therapeutics (PLRX) United States $0.665B 0.00
Immatics (IMTX) Germany $0.650B 0.00
Bicara Therapeutics (BCAX) United States $0.649B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Immunome (IMNM) United States $0.637B 0.00
Tectonic Therapeutic (TECX) United States $0.620B 0.00
Pharming Group (PHAR) Netherlands $0.617B 0.00
Cullinan Therapeutics (CGEM) United States $0.612B 0.00
Kura Oncology (KURA) United States $0.611B 0.00
Arbutus Biopharma (ABUS) United States $0.610B 0.00
Opthea (OPT) Australia $0.602B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.595B 0.00
Emergent Biosolutions (EBS) United States $0.589B 0.00
CARGO Therapeutics (CRGX) United States $0.585B 0.00
Humacyte (HUMA) United States $0.578B 0.00
Upstream Bio (UPB) United States $0.577B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.575B 0.00
Erasca (ERAS) United States $0.546B 0.00
MaxCyte (MXCT) United States $0.535B 0.00
Stoke Therapeutics (STOK) United States $0.531B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.514B 0.00
Mineralys Therapeutics (MLYS) United States $0.507B 0.00
Rapport Therapeutics (RAPP) United States $0.504B 0.00
AnaptysBio (ANAB) United States $0.492B 0.00
Cartesian Therapeutics (RNAC) United States $0.484B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.478B 0.00
MeiraGTx Holdings (MGTX) United States $0.472B 0.00
Entrada Therapeutics (TRDA) United States $0.469B 7.89
Absci (ABSI) United States $0.463B 0.00
Keros Therapeutics (KROS) United States $0.461B 0.00
GH Research (GHRS) Ireland $0.458B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.453B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.453B 0.00
ChromaDex (CDXC) United States $0.452B 592.00
Alpha Teknova (TKNO) United States $0.445B 0.00
Annexon (ANNX) United States $0.442B 0.00
Kamada (KMDA) Israel $0.433B 26.89
Sage Therapeutics (SAGE) United States $0.429B 0.00
Kodiak Sciences (KOD) United States $0.424B 0.00
Astria Therapeutics (ATXS) United States $0.423B 0.00
PureTech Health (PRTC) United States $0.420B 0.00
Celcuity (CELC) United States $0.418B 0.00
Prime Medicine (PRME) United States $0.417B 0.00
Allogene Therapeutics (ALLO) United States $0.403B 0.00
Terns Pharmaceuticals (TERN) United States $0.397B 0.00
Codexis (CDXS) United States $0.396B 0.00
Aura Biosciences (AURA) United States $0.396B 0.00
Abivax SA (ABVX) France $0.395B 0.00
REGENXBIO (RGNX) United States $0.389B 0.00
Northwest Biotherapeutics (NWBO) United States $0.384B 0.00
Eton Pharmaceuticals (ETON) United States $0.382B 0.00
Revance Therapeutics (RVNC) United States $0.381B 0.00
MBX Biosciences (MBX) United States $0.363B 0.00
Compass Therapeutics (CMPX) United States $0.355B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.350B 0.00
Zenas BioPharma (ZBIO) United States $0.348B 0.00
Chimerix (CMRX) United States $0.340B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.340B 0.00
Neumora Therapeutics (NMRA) United States $0.336B 0.00
Precigen (PGEN) United States $0.331B 0.00
Tango Therapeutics (TNGX) United States $0.331B 0.00
Alumis (ALMS) United States $0.326B 0.00
Olema Pharmaceuticals (OLMA) United States $0.325B 0.00
EnGene Holdings (ENGN) Canada $0.307B 0.00
XOMA Royalty (XOMA) United States $0.307B 0.00
Voyager Therapeutics (VYGR) United States $0.297B 7.65
ATyr Pharma (ATYR) United States $0.294B 0.00
Design Therapeutics (DSGN) United States $0.293B 0.00
Trevi Therapeutics (TRVI) United States $0.291B 0.00
Contineum Therapeutics (CTNM) United States $0.289B 0.00
Prima BioMed (IMMP) Australia $0.285B 0.00
ITeos Therapeutics (ITOS) United States $0.282B 0.00
Rezolute (RZLT) United States $0.279B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.277B 0.00
AC Immune (ACIU) Switzerland $0.268B 0.00
Atea Pharmaceuticals (AVIR) United States $0.264B 0.00
Third Harmonic Bio (THRD) United States $0.263B 0.00
C4 Therapeutics (CCCC) United States $0.262B 0.00
DiaMedica Therapeutics (DMAC) United States $0.258B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.254B 0.00
Nautilus Biotechnology (NAUT) United States $0.252B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.252B 0.00
Benitec Biopharma (BNTC) United States $0.248B 0.00
Verastem (VSTM) United States $0.246B 0.00
Foghorn Therapeutics (FHTX) United States $0.243B 0.00
Sangamo Therapeutics (SGMO) United States $0.240B 0.00
Lifecore Biomedical (LFCR) United States $0.238B 0.00
Anika Therapeutics (ANIK) United States $0.238B 0.00
Neurogene (NGNE) United States $0.237B 0.00
Semper Paratus Acquisition (TVGN) United States $0.236B 0.00
Urogen Pharma (URGN) United States $0.236B 0.00
BioStem Technologies (BSEM) $0.235B 20.74
Amarin (AMRN) Ireland $0.225B 0.00
Abeona Therapeutics (ABEO) United States $0.223B 0.00
Candel Therapeutics (CADL) United States $0.222B 0.00
Fulcrum Therapeutics (FULC) United States $0.221B 0.00
Ocugen (OCGN) United States $0.220B 0.00
Molecular Partners AG (MOLN) Switzerland $0.215B 0.00
Compugen (CGEN) Israel $0.212B 119.00
Zhengye Biotechnology Holding (ZYBT) China $0.210B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.207B 0.00
Monopar Therapeutics (MNPR) United States $0.205B 0.00
Gossamer Bio (GOSS) United States $0.204B 0.00
ACELYRIN, INC (SLRN) United States $0.203B 0.00
TuHURA Biosciences (HURA) United States $0.202B 0.00
Inhibrx Biosciences (INBX) United States $0.197B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.196B 0.00
Actuate Therapeutics (ACTU) United States $0.195B 0.00
BioAge Labs (BIOA) United States $0.183B 0.00
Adocia (ADOCY) France $0.183B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.183B 0.00
Cardiff Oncology (CRDF) United States $0.181B 0.00
GENFIT S.A (GNFT) France $0.180B 0.00
Nkarta (NKTX) United States $0.175B 0.00
Alector (ALEC) United States $0.174B 0.00
INmune Bio (INMB) United States $0.170B 0.00
Greenwich LifeSciences (GLSI) United States $0.167B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.164B 0.00
Sutro Biopharma (STRO) United States $0.162B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.161B 0.00
ScPharmaceuticals (SCPH) United States $0.161B 0.00
Akoya Biosciences (AKYA) United States $0.159B 0.00
Artiva Biotherapeutics (ARTV) United States $0.159B 0.00
Adherex Technologies (FENC) United States $0.158B 0.00
Biomea Fusion (BMEA) United States $0.157B 0.00
Seres Therapeutics (MCRB) United States $0.156B 0.00
Cidara Therapeutics (CDTX) United States $0.155B 0.00
Ventyx Biosciences (VTYX) United States $0.153B 0.00
Fate Therapeutics (FATE) United States $0.153B 0.00
Coherus BioSciences (CHRS) United States $0.151B 0.00
Innate Pharma S.A (IPHA) France $0.148B 0.00
Bright Minds Biosciences (DRUG) United States $0.148B 0.00
Black Diamond Therapeutics (BDTX) United States $0.148B 0.00
InflaRx (IFRX) Germany $0.147B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.147B 0.00
Puma Biotechnology (PBYI) United States $0.145B 6.15
Kyverna Therapeutics (KYTX) United States $0.142B 0.00
Seer (SEER) United States $0.140B 0.00
Caribou Biosciences (CRBU) United States $0.138B 0.00
Checkpoint Therapeutics (CKPT) United States $0.135B 0.00
TScan Therapeutics (TCRX) United States $0.134B 0.00
Sagimet Biosciences (SGMT) United States $0.130B 0.00
2seventy Bio (TSVT) United States $0.130B 0.00
Instil Bio (TIL) United States $0.129B 0.00
Renovaro (RENB) United States $0.126B 0.00
Climb Bio (CLYM) United States $0.126B 0.00
Solid Biosciences (SLDB) United States $0.125B 0.00
Cabaletta Bio (CABA) United States $0.124B 0.00
Alto Neuroscience (ANRO) United States $0.122B 0.00
Aligos Therapeutics (ALGS) United States $0.118B 0.00
Nuvectis Pharma (NVCT) United States $0.118B 0.00
CAMP4 Therapeutics (CAMP) United States $0.117B 0.00
Zura Bio (ZURA) United States $0.117B 0.00
XBiotech (XBIT) United States $0.115B 0.00
Inventiva S.A (IVA) France $0.114B 0.00
Elutia (ELUT) United States $0.111B 0.00
Editas Medicine (EDIT) United States $0.111B 0.00
Genelux (GNLX) United States $0.109B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.106B 0.00
TELA Bio (TELA) United States $0.105B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.105B 0.00
Tenaya Therapeutics (TNYA) United States $0.101B 0.00
IGM Biosciences (IGMS) United States $0.101B 0.00
Allakos (ALLK) United States $0.100B 0.00
DBV Technologies S.A (DBVT) France $0.098B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.096B 0.00
ALX Oncology Holdings (ALXO) United States $0.095B 0.00
Alpha Cognition (ACOG) Canada $0.095B 0.00
HilleVax (HLVX) United States $0.095B 0.00
Coya Therapeutics (COYA) United States $0.095B 0.00
Citius Oncology (CTOR) United States $0.094B 0.00
Adverum Biotechnologies (ADVM) United States $0.093B 0.00
23andMe Holding (ME) United States $0.092B 0.00
BioHarvest Sciences (BHST) Canada $0.091B 0.00
Jasper Therapeutics (JSPR) United States $0.090B 0.00
Vor Biopharma (VOR) $0.090B 0.00
Entera Bio (ENTX) Israel $0.089B 0.00
MediciNova (MNOV) United States $0.089B 0.00
Immunic (IMUX) United States $0.089B 0.00
Leap Therapeutics (LPTX) United States $0.088B 0.00
I-Mab (IMAB) China $0.087B 0.00
Agenus (AGEN) United States $0.086B 0.00
Rani Therapeutics Holdings (RANI) United States $0.085B 0.00
Cellectis S.A (CLLS) France $0.085B 0.00
Scilex Holding (SCLX) United States $0.084B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.084B 0.00
Inozyme Pharma (INZY) United States $0.084B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.083B 0.00
VistaGen Therapeutics (VTGN) United States $0.083B 0.00
X4 Pharmaceuticals (XFOR) United States $0.083B 0.00
Vigil Neuroscience (VIGL) United States $0.083B 0.00
Elicio Therapeutics (ELTX) United States $0.081B 0.00
Galena Biopharma (SLS) United States $0.080B 0.00
Adagene (ADAG) China $0.080B 0.00
Theratechnologies (THTX) Canada $0.079B 0.00
Skye Bioscience (SKYE) United States $0.079B 0.00
BGM Group (BGM) China $0.077B 0.00
Adlai Nortye (ANL) Cayman Islands $0.077B 0.00
Cue Biopharma (CUE) United States $0.077B 0.00
Bluebird Bio (BLUE) United States $0.076B 0.00
Adicet Bio (ACET) United States $0.076B 0.00
Aadi Bioscience (AADI) United States $0.074B 0.00
Annovis Bio (ANVS) United States $0.073B 0.00
Applied Therapeutics (APLT) United States $0.073B 0.00
Aerovate Therapeutics (AVTE) United States $0.073B 0.00
Genenta Science S.p.A (GNTA) Italy $0.073B 0.00
Clearside Biomedical (CLSD) United States $0.072B 0.00
Ikena Oncology (IKNA) United States $0.071B 0.00
Invizyne Technologies (IZTC) United States $0.071B 0.00
Oncolytics Biotech (ONCY) Canada $0.070B 0.00
Abpro Holdings (ABP) United States $0.070B 0.00
Quince Therapeutics (QNCX) United States $0.069B 0.00
BeyondSpring (BYSI) United States $0.068B 0.00
CytomX Therapeutics (CTMX) United States $0.066B 4.93
Immuneering (IMRX) United States $0.066B 0.00
Mersana Therapeutics (MRSN) United States $0.065B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.065B 0.00
PepGen (PEPG) United States $0.065B 0.00
Generation Bio (GBIO) United States $0.064B 0.00
ZIVO Bioscience (ZIVO) United States $0.063B 0.00
PDS Biotechnology (PDSB) United States $0.063B 0.00
Werewolf Therapeutics (HOWL) United States $0.061B 0.00
Kronos Bio (KRON) United States $0.060B 0.00
FibroBiologics (FBLG) United States $0.060B 0.00
IO Biotech (IOBT) Denmark $0.059B 0.00
Inovio Pharmaceuticals (INO) United States $0.059B 0.00
Boundless Bio (BOLD) United States $0.057B 0.00
Earth Science Tech (ETST) United States $0.057B 0.00
Connect Biopharma Holdings (CNTB) United States $0.056B 0.00
Immix Biopharma (IMMX) United States $0.054B 0.00
Shattuck Labs (STTK) United States $0.053B 0.00
Rein Therapeutics (RNTX) United States $0.053B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.052B 0.00
Oncobiologics (OTLK) United States $0.052B 0.00
Repare Therapeutics (RPTX) Canada $0.051B 0.00
Celularity (CELU) United States $0.051B 0.00
Fortress Biotech (FBIO) United States $0.050B 0.00
Ovid Therapeutics (OVID) United States $0.050B 0.00
Invivyd (IVVD) United States $0.049B 0.00
Lantern Pharma (LTRN) United States $0.048B 0.00
Spero Therapeutics (SPRO) United States $0.048B 12.49
Achilles Therapeutics (ACHL) United Kingdom $0.047B 0.00
Kezar Life Sciences (KZR) United States $0.047B 0.00
Dyadic (DYAI) United States $0.046B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.046B 0.00
VTv Therapeutics (VTVT) United States $0.043B 0.00
Rapt Therapeutics (RAPT) United States $0.043B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.042B 0.00
Q32 Bio (QTTB) United States $0.042B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.042B 0.00
Estrella Immunopharma (ESLA) United States $0.041B 0.00
MiNK Therapeutics (INKT) United States $0.040B 0.00
Atara Biotherapeutics (ATRA) United States $0.040B 0.00
Grace Therapeutics (GRCE) Canada $0.040B 0.00
CalciMedica (CALC) United States $0.040B 0.00
Elevation Oncology (ELEV) United States $0.040B 0.00
Xilio Therapeutics (XLO) United States $0.039B 0.00
Clene (CLNN) United States $0.039B 0.00
Intensity Therapeutics (INTS) United States $0.039B 0.00
Precision BioSciences (DTIL) United States $0.038B 0.00
AN2 Therapeutics (ANTX) United States $0.038B 0.00
Passage Bio (PASG) United States $0.037B 0.00
Rallybio (RLYB) United States $0.036B 0.00
RenovoRx (RNXT) United States $0.036B 0.00
Cadrenal Therapeutics (CVKD) United States $0.035B 0.00
KALA BIO (KALA) United States $0.035B 0.00
UNITY Biotechnology (UBX) United States $0.035B 0.00
OKYO Pharma (OKYO) $0.035B 0.00
Lexaria Bioscience (LEXX) Canada $0.035B 0.00
SAB Biotherapeutics (SABS) United States $0.034B 0.00
Enzo Biochem (ENZ) United States $0.034B 0.00
Opus Genetics (IRD) United States $0.034B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.033B 0.00
Cognition Therapeutics (CGTX) United States $0.032B 0.00
Promis Neurosciences (PMN) Canada $0.031B 0.00
Medicus Pharma (MDCX) Canada $0.030B 0.00
Chemomab Therapeutics (CMMB) Israel $0.030B 0.00
Beyond Air (XAIR) United States $0.029B 0.00
Dare Bioscience (DARE) United States $0.029B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.028B 0.00
Curis (CRIS) United States $0.028B 0.00
Exicure (XCUR) United States $0.027B 0.00
Omega Therapeutics (OMGA) United States $0.026B 0.00
Femasys (FEMY) United States $0.026B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.026B 0.00
Longeveron (LGVN) United States $0.026B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.025B 0.00
Gelteq (GELS) Australia $0.025B 0.00
BioAtla (BCAB) United States $0.024B 0.00
HOOKIPA Pharma (HOOK) United States $0.024B 0.00
Prana Biotechnology (ATHE) Australia $0.024B 0.00
LakeShore Biopharma (LSB) China $0.024B 0.00
Pluri (PLUR) Israel $0.023B 0.00
Forte Biosciences (FBRX) United States $0.023B 0.00
Cyclo Therapeutics (CYTH) United States $0.023B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
Equillium (EQ) United States $0.022B 0.00
Pulmatrix (PULM) United States $0.022B 0.00
NextCure (NXTC) United States $0.022B 0.00
Tenax Therapeutics (TENX) United States $0.022B 0.00
Cara Therapeutics (CARA) United States $0.022B 0.00
Aprea Therapeutics (APRE) United States $0.022B 0.00
Bionano Genomics (BNGO) United States $0.022B 0.00
Athira Pharma (ATHA) United States $0.021B 0.00
Senti Biosciences (SNTI) United States $0.021B 0.00
Cocrystal Pharma (COCP) United States $0.020B 0.00
Bolt Biotherapeutics (BOLT) United States $0.020B 0.00
GeoVax Labs (GOVX) United States $0.020B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.020B 0.00
OnKure Therapeutics (OKUR) United States $0.019B 0.00
IN8bio (INAB) United States $0.019B 0.00
BioXcel Therapeutics (BTAI) United States $0.018B 0.00
NKGen Biotech (NKGN) United States $0.018B 0.00
BRIACELL THERAP (BCTX) Canada $0.018B 0.00
Affimed (AFMD) Germany $0.018B 0.00
Palvella Therapeutics (PVLA) United States $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
Ocean Biomedical (OCEA) United States $0.016B 0.00
MetaVia (MTVA) United States $0.016B 0.00
Cingulate (CING) United States $0.016B 0.00
Biorestorative Therapies (BRTX) United States $0.016B 0.00
Spruce Biosciences (SPRB) United States $0.016B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.015B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.014B 0.00
Sensei Biotherapeutics (SNSE) United States $0.014B 0.00
CervoMed (CRVO) United States $0.013B 0.00
Imunon (IMNN) United States $0.013B 0.00
HCW Biologics (HCWB) United States $0.013B 0.00
Aptose Biosciences (APTO) Canada $0.013B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.012B 0.00
Ensysce Biosciences (ENSC) United States $0.011B 0.00
Aytu BioPharma (AYTU) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Apollomics (APLM) United States $0.011B 0.00
BioAffinity Technologies (BIAF) United States $0.010B 0.00
Turnstone Biologics (TSBX) United States $0.010B 0.00
Evogene (EVGN) Israel $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Carmell (CTCX) United States $0.010B 0.00
Hoth Therapeutics (HOTH) United States $0.009B 0.00
Mainz Biomed (MYNZ) Germany $0.009B 0.00
Silo Pharma (SILO) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Galecto (GLTO) Denmark $0.007B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Quantum Biopharma (QNTM) Canada $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
GENPREX (GNPX) United States $0.006B 0.00
Polyrizon (PLRZ) Israel $0.006B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
Eyenovia (EYEN) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Edesa Biotech (EDSA) Canada $0.006B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.006B 0.00
GRI Bio (GRI) United States $0.006B 0.00
Novogen (KZIA) Australia $0.006B 0.00
CNS Pharmaceuticals (CNSP) United States $0.006B 0.00
Moleculin Biotech (MBRX) United States $0.006B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.006B 0.00
Syros Pharmaceuticals (SYRS) United States $0.006B 0.00
Organovo Holdings (ONVO) United States $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Purple Biotech (PPBT) Israel $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Allarity Therapeutics (ALLR) United States $0.004B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.004B 0.00
Portage Biotech (PRTG) $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
Mustang Bio (MBIO) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Vincerx Pharma (VINC) United States $0.004B 0.00
Dogwood Therapeutics (DWTX) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
Eterna Therapeutics (ERNA) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
Pasithea Therapeutics (KTTA) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
NuCana (NCNA) United Kingdom $0.003B 0.00
Evaxion Biotech (EVAX) Denmark $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
NAYA Biosciences (NAYA) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.002B 0.00
Psyence Biomedical (PBM) Canada $0.001B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.001B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.001B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00